| Name | Antitumor agent-101 |
|---|
| Description | Antitumor agent-101 is a selective covalent inhibitor of lysine methyltransferases G9a/GLP, with IC50s of 8.5 nM and 5.5 nM for G9a and GLP, respectively. Antitumor agent-101 shows antitumor efficacy in the PANC-1 xenograft model[1]. |
|---|---|
| Related Catalog | |
| Target |
G9a:8.5 nM (IC50) GLP:5.5 nM (IC50) |
| References |
| Molecular Formula | C26H38N6O3 |
|---|---|
| Molecular Weight | 482.62 |